Arne is a Communications, Advocacy and Policy executive with more than 22 years of experience in the global biotech and biopharma industries, and in non-profit. He brings robust experience in all types of communications (corporate, investor, pipeline, product, access, crisis, and employee communications, as well as media and public relations) across the entire value chain (from discovery to life-cycle management), and a wide range of therapeutic areas and modalities (small molecules, vaccines, biologics, and gene therapy), in common and rare diseases.
Prior to working with Consilium, Arne held leading roles in small start-up, mid-size, and large commercial organizations, including Freeline Therapeutics, Inc., Alexion Pharmaceuticals, Inc. (today AstraZeneca), the International AIDS Vaccine Initiative, GSK Vaccines, Sanofi Pasteur MSD, and Aventis (today Sanofi).
Arne is a trusted C-suite and expert counsel, and a strategic thinker and storyteller with sharp business and financial acumen, and strong scientific background. Prior to his industry career, Arne was a journalist in top-tier broadcast and print media.
A German and French citizen, Arne has spent half of his career in Europe (Germany, France and Belgium) and the other half in the U.S., which has taught him intercultural awareness and understanding. He is fluent in English, French and German.
Arne holds a PhD in Biochemistry from the Ludwig-Maximilians University in Munich, Germany, and the Centre d’Etudes de Saclay, France, and master’s degree in chemistry from the University of Hamburg, Germany.
